Trial Information

Summary: A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Patients with Opioid-induced Bowel Dysfunction

This is a study to assess the efficacy and safety of oral lubiprostone for Opioid-Induced Bowel Dysfunction.

Patient Inclusion Criteria

  • At least 18 years of age
  • Have been treated consistently for chronic, non-cancer-related pain with any type of opioid therapy for at least 30 days prior to screening and will continue opioid therapy throughout the study
  • Have Opioid-induced Bowel Dysfunction

Contact:

Lovelace Scientific Resources, Inc.
1037 Whitney Ranch Dr.
Henderson, NV 89014
Telephone: 1-888-315-9156
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:37:12 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA